Page last updated: 2024-11-12

9-fluorocortisone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID16118707
SCHEMBL ID4546
MeSH IDM0102592

Synonyms (12)

Synonym
9-fluorocortisone
9alpha-fluorocortisone
pregn-4-ene-3,11,20-trione, 9-fluoro-17,21-dihydroxy-
79-60-7
unii-9av2mhj5z6
9av2mhj5z6 ,
AKOS016004354
SCHEMBL4546
DTXSID101000179
(8s,9r,10s,13s,14s,17r)-9-fluoro-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthrene-3,11-dione
9.alpha.-fluorocortisone
corticosterone, 11-dehydro-9-fluoro-17-hydroxy-

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"To test the effect of a drug combination therapy on ocular perfusion in human eyes affected by idiopathic intermediate uveitis."( Effect of a drug combination treatment on ocular perfusion in recurrent idiopathic intermediate uveitis.
Cimino, L; Finzi, G; Gandolfi, SA; Mora, P; Orsoni, JG; Zavota, L, 2003
)
0.32
"In eyes affected by idiopathic intermediate uveitis, treated with a systemic drug combination therapy, the improvement of the visual acuity seems to correlate with a proportional improvement of the retrobulbar circulation."( Effect of a drug combination treatment on ocular perfusion in recurrent idiopathic intermediate uveitis.
Cimino, L; Finzi, G; Gandolfi, SA; Mora, P; Orsoni, JG; Zavota, L, 2003
)
0.32

Dosage Studied

ExcerptRelevanceReference
" The present work explored the effect of a modified dosage regimen of the drug in five patients."( Chronopharmacology of hydrocortisone and 9 alpha-fluorhydrocortisone in the treatment for congenital adrenal hyperplasia.
Moeller, H, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (44.44)18.7374
1990's5 (27.78)18.2507
2000's5 (27.78)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.28 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies7 (36.84%)4.05%
Observational0 (0.00%)0.25%
Other11 (57.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]